Interpretation of Positive Flow Cytometric Crossmatch in the Era of the Single-Antigen Bead Assay-Reference-Cited by-同舟云学术

Interpretation of Positive Flow Cytometric Crossmatch in the Era of the Single-Antigen Bead Assay

Published:2011-03-15 Issue:5 Volume:91 Page:527-535
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Couzi Lionel,Araujo Caroline,Guidicelli Gwendaline,Bachelet Thomas,Moreau Karine,Morel Delphine,Robert Grégoire,Wallerand Hervé,Moreau Jean-François,Taupin Jean-Luc,Merville Pierre

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference38 articles.

1. Significance of the positive crossmatch test in kidney transplantation.;Patel;N Engl J Med,1969

2. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: Identification of low levels of pre-formed antibodies in accelerated allograft rejection.;Johnson;Tissue Antigens,1972

3. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk.;Gebel;Am J Transplant,2003

4. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.;Kerman;Transplantation,1999

5. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.;Ogura;Transplantation,1993

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch Methods;Transplantation Direct;2024-08-08

2. Organtransplantation – Welche spenderspezifischen HLA-Antikörper sind akzeptabel?;Transfusionsmedizin;2023-11

3. BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation;International Journal of Immunogenetics;2023-11

4. Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines;Transplant International;2023-06-28

5. Evaluation of a new complement‐dependent lymphocytotoxicity cross match method using an automated cell counter, the NucleoCounter® NC‐3000™;HLA;2023-04-04